150 related articles for article (PubMed ID: 23975515)
1. Relationship between clinical data and gene expression in the HER2/ErbB2-dependent signaling pathway in patients with acute heart failure.
Szmit S; Jank M; Maciejewski H; Balsam P; Łój M; Filipiak KJ; Motyl T; Opolski G
J Appl Genet; 2013 Nov; 54(4):447-53. PubMed ID: 23975515
[TBL] [Abstract][Full Text] [Related]
2. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin1 as novel therapy for heart failure.
Yan X; Morgan JP
Curr Pharm Des; 2011; 17(18):1808-17. PubMed ID: 21631420
[TBL] [Abstract][Full Text] [Related]
4. The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy.
De Keulenaer GW; Doggen K; Lemmens K
Circ Res; 2010 Jan; 106(1):35-46. PubMed ID: 20056944
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation.
Rohrbach S; Niemann B; Silber RE; Holtz J
Basic Res Cardiol; 2005 May; 100(3):240-9. PubMed ID: 15685397
[TBL] [Abstract][Full Text] [Related]
6. Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.
Shin DH; Jo JY; Han JY
Mol Cancer Ther; 2018 Sep; 17(9):2024-2033. PubMed ID: 29959202
[TBL] [Abstract][Full Text] [Related]
7. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
8. IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish.
Samsa LA; Ito CE; Brown DR; Qian L; Liu J
PLoS One; 2016; 11(11):e0166734. PubMed ID: 27846271
[TBL] [Abstract][Full Text] [Related]
9. Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.
Dang R; Guo Y; Cai H; Yang R; Liang D; Lv C; Jiang P
J Toxicol Sci; 2016 Apr; 41(2):303-9. PubMed ID: 26961615
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes.
Munk M; Memon AA; Goetze JP; Nielsen LB; Nexo E; Sorensen BS
PLoS One; 2012; 7(7):e40243. PubMed ID: 22792252
[TBL] [Abstract][Full Text] [Related]
11. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
Choi BK; Fan X; Deng H; Zhang N; An Z
Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
[TBL] [Abstract][Full Text] [Related]
12. Nrg1/ErbB2 regulates differentiation and apoptosis of neural stem cells in the cochlear nucleus through PI3K/Akt pathway.
Lu F; Wei L; Yang C; Qiao Y; Liu YS; Chen XD; Wang J; Shi ZH; Chen FQ; Zha DJ; Xue T
Neurosci Lett; 2021 Apr; 751():135803. PubMed ID: 33705930
[TBL] [Abstract][Full Text] [Related]
13. Chronic stress and excessive glucocorticoid exposure both lead to altered Neuregulin-1/ErbB signaling in rat myocardium.
Dang R; Guo Y; Zhang L; Chen L; Yang R; Jiang P
Steroids; 2016 Aug; 112():47-53. PubMed ID: 27133902
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
16. A Role for Neuregulin-1 in Promoting Keloid Fibroblast Migration via ErbB2-mediated Signaling.
Jumper N; Hodgkinson T; Paus R; Bayat A
Acta Derm Venereol; 2017 Jun; 97(6):675-684. PubMed ID: 27882385
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
18. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.
Vijapurkar U; Kim MS; Koland JG
Exp Cell Res; 2003 Apr; 284(2):291-302. PubMed ID: 12651161
[TBL] [Abstract][Full Text] [Related]
19. Novel luciferase-based reporter system to monitor activation of ErbB2/Her2/neu pathway noninvasively during radiotherapy.
Wolf F; Li W; Li F; Li CY
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):233-8. PubMed ID: 20934271
[TBL] [Abstract][Full Text] [Related]
20. Study of inhibition effect of herceptin on interaction between heregulin and erbB receptors HER3/HER2 by single-molecule force spectroscopy.
Shi X; Xu L; Yu J; Fang X
Exp Cell Res; 2009 Oct; 315(16):2847-55. PubMed ID: 19497323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
